michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, Rockwell as a reseller has been growing and growing and growing, and most of that reselling is in the field of IoT and AR, let's be clear on that. And we have many other resellers, but they're largely in CAD and PLM. So Rockwell has become an important reseller for sure, of IoT and AR. And I don't see that ending. When I talk to Blake, about how this fits in with his strategy, even post Plex. Blake says, "Hey, I need an IoT platform, I need an AR platform, I even want to have a CAD and PLM platform available to me when required because his competitor, Siemens has that stuff, not all of IoT and AR, but some IoT and lots of CAD and PLM.
So we remain important to Blake, and there's nothing he acquired in the Plex acquisition that supplants any of the capabilities that PTC brought in the FactoryTalk Innovation Suite. So I think it's Blake and Rockwell's strategy, as I understand it, to add Plex to what they're already doing with PTC. And I don't have any issue that whatsoever because I think it's complementary.
And like I said, maybe even some upside opportunities. I just noted that we're going to be sharing some mind share with Rockwell, who now has kind of another child in the family, let's say, that's going to need some attention to. So I don't think it's going to materially change our partnership.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Dave.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So it's AlloHeme, and I think you saw the recent release we had with the ACROBAT study for the first patient enrolled for stem cell transplant, is not part of the solid organ universal LCDs. So that's the first thing. The second thing is, as we look at AlloHeme, it's being used in what we believe is the next-generation of chimerism. What the study itself is looking at is how do we measure obviously, staff -- stem cell engraftment. But what the study itself is trying to do is look at and measure relapse, which has never been done before. So I think, there are multiple different approaches to existing reimbursement or the future reimbursement.
But the important thing here is we want to drive innovation and saying that as a hallmark of the company, which is what we stand out for is innovation. And so we're trying to do is the thing, which hasn't been done before, which is now providing a test they can look at and measure relapse with in this approach. So that's what we're sort of taking but yes, there are multiple avenues of options for coverage.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, thanks, Oliver. That's a great question and ESG and sustainability overall is something that has been very important and it's important to each of our brands and it's important to Tapestry as a company. In fact, as we were forming Tapestry as a company a few years ago, we talked about how ESG needed to be part of the fabric of our company and we created our social fabric which encompasses our ESG program, if you will, our goals and they're around people, communities and in our environment and so all 3 of those areas are focus areas of ours, as it relates to our people goals. It's about having more representation across our organization and in leadership and we continue to hold our teams accountable for progress, there is definitely more work we need to do there, but we remain very focused on it and as it relates to community, it's about how we impact our communities as a company and that's through our foundation and the work our foundations do, but also through volunteering efforts from our teams and I would say, lastly on the environment, we're very focused on our carbon footprint and the impact and traceability of our supply chain. So those are some of the areas of focus. It is a very important element of our strategies going forward and we're holding ourselves accountable to making progress on our goals.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It does. I'm a little disoriented about 9:00 AM too, I'm still trying to get used to that.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Ed.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Like Doug mentioned a little bit earlier, the immune health continues to be the product line that's outpacing anything else. And then, and when we look at it, we did a lot of programs throughout 2021 from a promotional activity as well from incentives as well as product launches, I mean, we launch more products in 2020 than we ever have. And that was part of our overall strategy to create some growth in the markets and lessen the distractions that COVID-19 and -- but again that immune health is continuing to be the line that's moving forward. I would say in 2021, hopefully when we are talking about it, that Active Nutrition would be the catalyst throughout the year when it comes to new product launches. But I don't see the demand for immune health to really go down in 2021.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So Andrew, we clearly are seeing improvement in access and increase in patients returning to the oncology offices. I wouldn't say we're back to, again, sort of normal or pre-pandemic levels, and we expect that the improvement will continue. I think the thing that is positive for us and why we remain very confident in 2022 and beyond is that as incidence of COVID drops, we do see access go up, we see patients come back, and our business follows ahead. It's not necessarily a switch of -- a change of the switch, but we're very confident that it will certainly continue to improve, and we look forward to a strong 2022.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, basically.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Returns would be very similar to what our regulated returns would be on either Transco or Northwest Pipeline once those rate case outcomes are known.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, travel retail is still far away from the level it was in 2019. As I said in my remarks, typically travel retail represents 15% to 20% and we are down 80% in 2020. There is still today, no real improvement in travel retail at least it was like this for the first quarter. We do not anticipate in our projections an improvement this year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It was an incredibly strong quarter. It set a June quarter revenue record for Greater China for us, and so we're very proud of that and doing the best job we can to serve customers there. We had a particularly strong response to the 12 Pro and the 12 Pro Max. Those results were particularly strong.
And if -- but if you look at the balance of our products, we also set June quarter records for wearables, home, and accessories for Mac and for services. So it was sort of an across-the-board strength. And we're seeing plenty of new customers come to the market. For example, Mac and iPad, about two-thirds of the customers who bought in the last quarter were new to that product.
For the Apple Watch, that number was 85%. And so we could not be happier with the results.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We do. I think that, again, we are open architecture and -- but we have the PMC team, have the qualitative portfolio. So we like when those are utilized by our advisors. And you see the growth rates that we experienced last year, so clearly, we're gaining a lot of traction there. I think what the advantage that we'll have is that they'll reside on our technology. We'll be able to look at overall client pricing when it comes to technology and product usage and other areas of leverage that we have to encourage advisors to take a hard look at our PMC quantitative portfolios.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. You will see some more activity until [Indecipherable] advertising will likely double our budget from last year on television.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. We signaled on this a little bit last quarter on our call. We've traditionally kind of been in the mid five's with the product we're buying. With some of the price increase, we've seen that kind of go into kind of the low to mid five's. So I think have been somewhere around 5% to 5.25% on a blended basis of what we've been buying in Q2. And that feels like the market right now. Fortunately, we are seeing a little bit more supply creep back into the marketplace. You're seeing listings, new listings kind of creep up, but we don't expect like some drastic change in supply. I would expect us to be hopefully around a 5% cap or a little bit better if we stayed at this pace.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I think so. I think that -- we're going to be more manufacturing and industrial and retail. Our retail business tends to be more into grocery and Big-Box kind of retail, but on the -- not necessarily produce but beverages and such. So, I think to the extent that we have a strong industrial recovery that would -- that could be a positive for us given our mix.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We're talking to so many of them about it, especially as we look to convert some of our properties into industrial, so those discussions are happening regularly. I'd say Target and Best Buy are probably doing the best job in that regard, Chris, I don't know if you want to make any more comments.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's perhaps also worth mentioning Jonathan in response to your question, we have around GBP40 billion of maturities this year in the hedge. So again, we've taken an incredibly prudent position vis-a-vis the cushion of the hedge i.e. eligible deposits have increased much faster than our edge capacity, number one. Number two, in addition to that, we have GBP40 billion of maturities in hedge this year. So, it's really quite substantial, the buffer.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. This is Joy Zhang on for Stephanie. Just one question from me. We've started to see some of your peers pivot to a surround-sound strategy with greater focus on adjacencies across the EHR. Now you've already made some investments there historically. So I was hoping to hear a refresh on some of the areas in your portfolio where you've got the highest level of excitement? And any other adjacencies that you'd like to enter?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. We haven't really talked a great deal about the trial design, up to this point. And in fact, I think our usual intent is to do that, when the trial is posted on clinicaltrials.gov, which will be later this year. What I would say, though, is that, given that this is a very rare pediatric epilepsy and actually has quite heterogeneous phenotype in terms of its -- how it expresses itself in terms of seizure type, seizure frequency.
But actually, it can be very devastating, as you may know, for patients from a very young age. The important thing for us was to ensure in our interactions with the agencies that every single patient, that we enrolled in this program would count, toward the ability for us to bring this to patients and register the medication.
And so the way in which the trial will be designed is to enable us to have the best opportunity of it being a registration-quality trial. And we're working through that even in the context of starting in the older adolescent population. And then, moving ultimately into pediatrics, where obviously a large amount of the value will be derived.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. So as I mentioned in my comments, it certainly was a good quarter for billings. So -- and I wasn't going to complain about 41% billings growth year over year. But we do note that we did do a number of large multiyear deals within the quarter, and we also had a few renewals that because of expansion activity were brought forward.
That being said, across the board, all of our teams executed well. And so we saw a high volume of transactions, even a lot of smaller transactions, and all of that contributed to a healthy billings number.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No, Scott. It's not a huge issue for us in this year. I mean a lot of the stuff, too, when you think about what's coming online, think about capacity at Cepheid, that's pretty good margin for us. So if anything, it's probably on the margin, helpful, but it won't be a big drag.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Okay.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Chris.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks for taking the questions. Good afternoon. Maybe just first one, you alluded to backfilling the largest vacancy in the portfolio. Maybe just give us some more details about that lease and what that -- if that were in place, sort of what does that do to total NOI?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It is not a constraint at current levels, I mean, outside of the labor challenges we see. But as we model out the long-term growth dynamics of the business and certainly, the regulation changes that are coming down the pipe, it's important for our longer-term plans.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. Thanks, Dan.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure, so this was actually a formal invitation by the U.S. Army to conduct a demonstration. You know, all the key selected players to come in and demonstrate their capability. This was primarily to see how far along and mature the solution sets are from various competitors as well as to inform them in terms of the requirements that they're going to sort of finalize and conclude before they actually really hold the competition in terms of a formal RFI or RFP.
They haven't announced any specific milestones as a result of this so far. It is a longer-term program, which I believe it's expected to be able to be awarded within another year and a half to two years, but in general, what really impressed me and what I'm very pleased about is that our solution set performed extremely well despite the very difficult challenges in terms of the environmental conditions, wind conditions in the scenarios that the customer obviously creates for us. We believe that our team and our system really performed well. So that is a fairly positive sign for us that at least positions us quite well. We still have to compete and we are no -- we're not unfamiliar with that. We're very familiar with that, but I think we're positioned quite well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think, Google auto renew -- not auto renew, sorry. Google renewal would be for next year. Yandex is in -- I think it's 2022 or 2023.

    Prediction (one of UP, DOWN, SAME): SAME